v3.3.0.814
Fair Value Measurements (Tables)
|
9 Months Ended |
|
Fair Value Disclosures [Abstract] |
|
Schedule of Fair Value of Financial Instruments |
The fair value of these instruments was as follows (in thousands): | | | | | | | | | | | | | | | | | | | | Fair Value | | Level 1 | | Level 2 | | Level 3 | Assets | | | | | | | | Money market funds | $ | 72,454 |
| | $ | 72,454 |
| | $ | — |
| | $ | — |
| U.S. government agency obligations | 53,721 | | — |
| | 53,721 | | — |
| Total assets measured at fair value | $ | 126,175 |
| | $ | 72,454 |
| | $ | 53,721 |
| | $ | — |
| | | | | | | | | Liabilities | | | | | | | | Derivative liabilities associated with the Medicis settlement | $ | 1,481 |
| | $ | — |
| | $ | — |
| | $ | 1,481 |
| Total liabilities measured at fair value | $ | 1,481 |
| | $ | — |
| | $ | — |
| | $ | 1,481 |
|
| | | | | | | | | | | | | | | | | | | | Fair Value | | Level 1 | | Level 2 | | Level 3 | Assets | | | | | | | | Money market funds | $ | 166,038 |
| | $ | 166,038 |
| | $ | — |
| | $ | — |
| Total assets measured at fair value | $ | 166,038 |
| | $ | 166,038 |
| | $ | — |
| | $ | — |
| | | | | | | | | Liabilities | | | | | | | | Derivative liabilities associated with the Medicis settlement | $ | 1,541 |
| | $ | — |
| | $ | — |
| | $ | 1,541 |
| Total liabilities measured at fair value | $ | 1,541 |
| | $ | — |
| | $ | — |
| | $ | 1,541 |
|
|
Summary of Changes in Fair Value of Financial Instruments |
The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial instruments as follows (in thousands): | | | | | | Derivative Liability Associated with the Medicis Settlement | | $ | 1,541 |
| Change in fair value | (60 | ) | | $ | 1,481 |
|
|
X |
- DefinitionTabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.
+ References
+ Details
Name: |
us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_FairValueDisclosuresAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
+ Details
Name: |
us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
|